We are live on ! Find out more
PIM

Platinum Investment Management Portfolio holdings

AUM $397M
1-Year Est. Return 63.96%
This Fund
S&P 500
This Quarter Est. Return
+15.75%
1 Year Est. Return
+63.96%
3 Year Est. Return
+135%
5 Year Est. Return
+149.46%
10 Year Est. Return
+636.06%
AUM
$5.05B
AUM Growth
+$579M
Cap. Flow
+$18.1M
Cap. Flow %
0.36%
Top 10 Hldgs %
56.49%
Holding
107
New
8
Increased
24
Reduced
25
Closed
9

Top Sells

Rank Stock Value
1
ATHM icon
Autohome
ATHM
+$103M
2
WB icon
Weibo
WB
+$78.5M
3
INTC icon
Intel
INTC
+$49.7M
4
SINA
Sina Corp
SINA
+$44.4M
5
BABA icon
Alibaba
BABA
+$35.4M

Sector Composition

Rank Sector Weight
1 Communication Services 21.45%
2 Technology 21.15%
3 Consumer Discretionary 18.79%
4 Industrials 14.36%
5 Energy 7.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATHM icon
76
Autohome
ATHM
$2.62B
$1.41M 0.03%
17,640
-1,318,249
-99% -$103M
ADI icon
77
Analog Devices
ADI
$190B
$1.27M 0.03%
10,720
PACB icon
78
Pacific Biosciences
PACB
$370M
$1.27M 0.03%
+247,475
New +$1.26M
OVID icon
79
Ovid Therapeutics
OVID
$491M
$1.27M 0.03%
306,146
+176,546
+136% +$557K
JD icon
80
JD.com
JD
$44.5B
$1.26M 0.03%
35,800
FPRX
81
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$1.15M 0.02%
251,216
+59,979
+31% +$238K
ALKS icon
82
Alkermes
ALKS
$8.25B
$1.14M 0.02%
+55,885
New +$1.11M
PVLA
83
Palvella Therapeutics
PVLA
$2.27B
$1.1M 0.02%
3,798
INFI
84
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$1.09M 0.02%
1,137,647
RCUS icon
85
Arcus Biosciences
RCUS
$3.64B
$1.05M 0.02%
103,740
-33,153
-24% -$279K
EBAY icon
86
eBay
EBAY
$49.8B
$1.03M 0.02%
28,417
ROKU icon
87
Roku
ROKU
$22.7B
$991K 0.02%
7,398
NTLA icon
88
Intellia Therapeutics
NTLA
$1.67B
$971K 0.02%
66,170
SGEN
89
DELISTED
Seagen Inc. Common Stock
SGEN
$927K 0.02%
8,110
-8,550
-51% -$907K
XLNX
90
DELISTED
Xilinx Inc
XLNX
$900K 0.02%
9,209
ASLN
91
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$843K 0.02%
10,386
SINA
92
DELISTED
Sina Corp
SINA
$660K 0.01%
16,524
-1,157,781
-99% -$44.4M
WVE icon
93
Wave Life Sciences
WVE
$1.2B
$553K 0.01%
68,957
-1,985
-3% -$48.7K
TWLO icon
94
Twilio
TWLO
$36.6B
$416K 0.01%
4,229
APPN icon
95
Appian
APPN
$2.48B
$409K 0.01%
10,693
OSB
96
DELISTED
Norbord Inc.
OSB
$357K 0.01%
+13,344
New +$356K
LBTYA icon
97
Liberty Global Class A
LBTYA
$3.6B
$337K 0.01%
14,800
ARLO icon
98
Arlo Technologies
ARLO
$1.65B
-14,060
Closed -$48K
CRTO icon
99
Criteo S.A. Ordinary Shares
CRTO
$923M
-20,551
Closed -$384K
HTHT icon
100
Huazhu Hotels Group
HTHT
$13B
-287,311
Closed -$9.49M

Similar funds

Platinum Investment Management's Q4 2019 Portfolio in Review

As of Q4 2019, Platinum Investment Management held 107 positions worth $5.05B, up 13% from $4.47B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Platinum Investment Management's Q4 2019 filing shows 8 new, 24 increased, 25 reduced and 9 closed positions. Its largest new stake was SLB Ltd: 1,078,572 shares worth $43.4M. The largest sale was Autohome, an estimated $103M.

By sector, the portfolio is most concentrated in Communication Services at 21% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Platinum Investment Management's largest Q4 2019 buy was SLB Ltd: 1,078,572 shares worth $43.4M.
  • Platinum Investment Management added most to Trip.com Group in Q4 2019, an estimated $76.3M increase.
  • Platinum Investment Management's biggest Q4 2019 reduction was Autohome, cutting an estimated $103M.
  • Platinum Investment Management fully exited Huazhu Hotels Group in Q4 2019, selling an estimated $9.49M.
  • Platinum Investment Management's ten largest holdings make up 56% of its $5.05B portfolio in Q4 2019.
  • Platinum Investment Management opened 8 new positions and closed 9 in Q4 2019.
  • Platinum Investment Management's portfolio value rose 13% quarter-over-quarter to $5.05B.

Based on Platinum Investment Management's 13F filing for Q4 2019, filed 13 Feb 2020.